Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Obesity Week 2020New Drug Looks Good for Rare Genetic Severe Obesity'The impact of setmelanotide in the obesity clinic is likely to mean...an increase in genetic screening to identify a subset of patients that can benefit,' said an expert.
Medscape Medical News, November 24, 2020
Obesity Week 2020In Those With Obesity, Will Losing Weight Cut COVID-19 Severity? Patients with obesity are at high risk and should be treated similarly to the elderly or immunocompromised if they get COVID-19. But if they can lose weight, could they reduce their risk?
Medscape Medical News, November 16, 2020
Obesity Week 2020Major Breakthrough in Weight Loss With Semaglutide?The larger weight losses (over 20% in 36% of patients) will mean that more patients with obesity will be able to achieve a weight loss they are satisfied with, says the lead of a phase 3 trial.
'Hyperpalatable' Defined as Foods Driving the Obesity Epidemic"We believe that one of the drivers of the obesity epidemic is ready access to energy dense, hyperpalatable foods," says an
expert. Having a standard, universal definition is therefore key.
Medscape Medical News, Nov 18, 2019
Investigational Drug Promising in Obese Patients With DiabetesAn investigational agent originally developed for sarcopenia has shown promise in a phase 2 trial in those with obesity and
type 2 diabetes, leading to a loss of body fat as well as weight reduction.
